TrialAntimicrobial agents and chemotherapy2012

Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.

A H Diacon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.